- CBD or THC? Cannabis Product Labels Often Mislead, Study Finds
- AHA News: Straight Answers to Common Questions About COVID-19 Vaccines
- U.S. Health Agencies Call for Pause in J&J COVID Vaccine After 6 People Develop Clots
- Therapeutic Cancer Vaccine Shows Promise Against Multiple Tumor Types
- Health Highlights: April 13, 2021
- Newborns Won’t Get COVID Through Infected Mom’s Breast Milk: Study
- Physically Active at Work? It’s Not as Healthy as Leisure Exercise
- Americans Are Eating Less Healthily Everywhere, Except at School
- U.K. Variant Won’t Trigger More Severe COVID, Studies Find
- FDA Approves First AI Tool to Boost Colonoscopy Accuracy
Clinical Trials Update: May 21, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Chronic Obstructive Pulmonary Disease (COPD)
This study of an investigational drug for chronic obstructive pulmonary disease will last for 12 month and involve eight office visits.
The research site is in Columbus, Ohio.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/copd.aspx.
—–
Influenza
If you have the first signs of flu, you may qualify for this study of an investigational drug. It involves three clinic visits, five phone calls and two blood draws.
The research site is in Carrollton, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/influenza.aspx.
—–
GERD (Heartburn)
This study seeks adults who are taking a PPI drug for GERD, but are still having symptoms such as frequent heartburn.
The research site is in Raleigh, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gerd.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
